Forte Biosciences (FBRX) Revenue (2017 - 2019)

Forte Biosciences (FBRX) posted quarterly Revenue of $9000.0 for Q4 2019, little changed year-over-year from $9000.0 in Q4 2018, and little changed quarter-over-quarter from $9000.0 in Q3 2019.

Forte Biosciences (FBRX) Revenue (2017 - 2019) Analysis & Trends

Forte Biosciences (FBRX) has reported Revenue for 3 consecutive years, with $9000.0 the latest figure, recorded in Q4 2019.

  • In Q4 2019, Revenue changed 0.0% year-over-year to $9000.0; the TTM figure through Dec 2019 stood at $36000.0 (down 99.8% YoY), while the FY2019 annual figure was $36000.0, down 99.8% from the prior year.
  • Revenue steadied at $9000.0 in Q4 2019 per FBRX's latest filing, from $9000.0 in the prior quarter.
  • Across five years, Revenue topped out at $18.0 million in Q3 2018 and bottomed at $9000.0 in Q1 2018.
  • Historically, Revenue has averaged $1.6 million across 3 years, with a median of $9000.0 in 2018.
  • Annual changes were most pronounced in 2018 — Revenue jumped 179990.0% — and 2019, when it slumped 99.95%.
  • Forte Biosciences' Revenue stood at $10000.0 in 2017, then declined by 10.0% to $9000.0 in 2018, then changed by 0.0% to $9000.0 in 2019.
  • Business Quant data shows FBRX's Revenue at $9000.0 in Q4 2019, $9000.0 in Q3 2019, and $9000.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Forte Biosciences 1.63 Bn 1.28 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 9,000.00
Sep 30, 2019 9,000.00
Jun 30, 2019 9,000.00
Mar 31, 2019 9,000.00
Dec 31, 2018 9,000.00
Sep 30, 2018 18.01 Mn
Jun 30, 2018 9,000.00
Mar 31, 2018 9,000.00
Dec 31, 2017 10,000.00
Sep 30, 2017 10,000.00
Jun 30, 2017 10,000.00